2013 – Zydus Lanka

August 23, 2019

2013 – Received USFDA approval for initiating Phase I clinical trials of ZYDPLA1, a novel next generation orally active, small molecule DPP-4 inhibitor to treat Type 2 Diabetes

Newer Post

USE TO CONNECT

Cimune STAR evening – Cadila & CND division of Zydus, celebrated launch anniversary of the brand

Zydus received EUA from DCGI for ZyCoV-D, the only needle-free COVID vaccine in the world.

With the support of Drs and “The Perinatal Society of Sri Lanka”, Zydus conducted Patient awareness program on “COVID-19 & Pregnancy”